Evidence map›Paper›PMID 40071043›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2025

Synthesis, structural characterization, Hirshfeld surface analysis and QTAIM analysis of 3-(4-cyano-thio-phen-3-yl)-[1,2,4]selena-diazolo[4,5-

Alexander A Sapronov, Evgeny A Dukhnovsky, Alexey S Kubasov, Alexander S Novikov, Maria M Grishina, Ekaterina V Dobrokhotova, Milena R Komarovskikh, Namiq Q Shikhaliyev, Mehmet Akkurt, Ajaya Bhattarai and 1 more

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexander A SapronovPeoples' Friendship University of Russia, 6 Miklukho-Maklaya Street, Moscow, 117198, Russia.
Evgeny A DukhnovskyPeoples' Friendship University of Russia, 6 Miklukho-Maklaya Street, Moscow, 117198, Russia.
Alexey S KubasovKurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Leninsky Prosp. 31, 119071 Moscow, Russia.
Alexander S NovikovInstitute of Chemistry, Saint Petersburg State University, Universitetskaya Nab. 7/9, 199034 Saint Petersburg, Russia.ORCID https://orcid.org/0000-0001-9913-5324
Maria M GrishinaPeoples' Friendship University of Russia, 6 Miklukho-Maklaya Street, Moscow, 117198, Russia.
Ekaterina V DobrokhotovaPeoples' Friendship University of Russia, 6 Miklukho-Maklaya Street, Moscow, 117198, Russia.
Milena R KomarovskikhPeoples' Friendship University of Russia, 6 Miklukho-Maklaya Street, Moscow, 117198, Russia.
Namiq Q ShikhaliyevDepartment of Chemical Engineering, Baku Engineering University, Hasan Aliyev Street 120, Baku AZ0101, Azerbaijan.ORCID https://orcid.org/0000-0002-6842-151X
Mehmet AkkurtDepartment of Physics, Faculty of Sciences, Erciyes University, 38039 Kayseri, Türkiye.ORCID https://orcid.org/0000-0003-2421-0929
Ajaya BhattaraiDepartment of Chemistry, M.M.A.M.C (Tribhuvan University) Biratnagar, Nepal.ORCID https://orcid.org/0000-0002-2648-4686
Alexander G TskhovrebovResearch Institute of Chemistry, Peoples' Friendship University of Russia, Miklukho-Maklaya St., 6, Moscow 117198, Russian Federation.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The title compound, C

Indexed as

1,2,4-seleno­diazolechalcogen-hydrogen bondingcrystal structureHirshfeld surface analysis

Identifiers

PMID40071043
PMCPMC11891582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.